SOURCE: Market Pulse

August 02, 2006 08:30 ET

Market Pulse Breaking News Alert for Wednesday, August 2, 2006: THII -- Tasco's Bio-Matrix Scientific Unit Installs New, Cutting-Edge Stem Cell Technology in Preparation for Anticipated Sept.

2006 Grand Opening of Its Stem Cell Cryogenic Banking and Processing Facility!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA -- (MARKET WIRE) -- August 2, 2006 -- Market Pulse News Alert for this AM, Stocks to Watch are: Tasco Holdings International, Inc. (OTCBB: THII), Cendant Corp. (NYSE: CD), Solar Enertech Corp. (OTCBB: SOEN), and ViroPharma Inc. (NASDAQ: VPHM).

Investors need to be watching Tasco Holdings International, Inc. (OTCBB: THII) this AM! Tasco Holdings is a development stage company engaged in biotech research. Tasco Holdings operates mainly through its recently acquired wholly owned subsidiary Bio-Matrix Scientific Group Inc. Bio-Matrix is engaged in the cryogenic storage of non-controversial stem cells and development of medical devices used in live tissue transfer and stem cell research. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Bio-Matrix has developed approximately 192 disposable instruments for use in plastic surgery, tissue management and stem cell research. These instruments have been designed to harvest adult stem cells from adipose tissue (extracted primarily during liposuction procedures). Due to the increasing number of liposuctions in the U.S., there should be a significant demand for the processing and storage of stem cells from fat tissue. Tasco/Bio-Matrix may become the first company to operate an adipose-derived stem cell bank in the U.S. Bio-Matrix has a four pronged revenue strategy each with a different trajectory but essentially meeting the company's core objectives of developing or acquiring patented or proprietary technology that can be converted into a steady revenue stream, either by manufacturing products or licensing the technology. Management expects to realize a total of approximately $4 million for its stem cell banking operations in 2007 itself. In the years 2008 and 2009, this operation is expected to yield revenues of approximately $14.07 million and $26.22 million, respectively. THII seeks to improve on its innovative therapies and its state-of-the-art facilities to grow its market position in the $75 billion biotech and medical device industry. Tasco Holdings International recently was rated "Outperform" with a target price of $6.00 by Beacon Equity Senior Research Analyst, Kris Goldcross, CFA. THII has had several excellent news announcements out lately and one again before today's opening bell announcing that it has received and installed a CBS Isothermal liquid nitrogen vapor storage tank and a K Series cryo-storage tank for stem cell storage! The company also announced that revenues are anticipated in the fourth quarter of 2006 once the facility is opened! This could be great news for investors!

Tasco Holdings International's (OTCBB: THII) wholly owned subsidiary Bio-Matrix Scientific Group Inc. (a Nevada corporation) a biotechnology company focused on stem cell cryogenics and disposable stem cell/tissue transfer instruments, announced today that it has received and installed a CBS Isothermal liquid nitrogen vapor storage tank and a K Series cryo-storage tank for stem cell storage.

As Bio-Matrix builds its state-of-the-art stem cell research and storage facility in San Diego, California, the company will utilize the new CBS V5000 cryo-tank as the flagship for cellular storage at the facility. This new technology will validate central liquid nitrogen supply that feeds all units housed at the Bio-Matrix facility.

"An investment in this new, V-5000 Isothermal Liquid Nitrogen tank and K Series tank, allows Bio-Matrix to enter into system testing, which will lead to accepting stem cell storage. This is an important step toward establishing the company's Good Manufacturing Practices (cGMPs) and Good Tissue Practices (cGTP) quality systems which is an important part of our facility master validation plan that will enhance our ability to provide superior stem cell storage over the long term," said Bio-Matrix Scientific Group Managing Director and COO Brian Pockett.

A company spokesperson said the company expects to open the facility for business by the end of September 2006, anticipating revenue in the 4th Quarter of 2006.

Bio-Matrix's new 15,000 sq ft, state-of-the-art facility, located in the heart of San Diego, will house the nation's premiere center for stem cell storage, including: Bio-Matrix's secure Cryogenic Stem Cell Bank, four research laboratories, aseptic cellular/tissue processing rooms, hematology, microbiology and flow cytometry laboratories.

About Bio-Matrix Scientific Group Inc.

Bio-Matrix Scientific Group Inc. researches, develops and commercializes medical devices and monitoring systems in the stem cell research industry. The Company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation.

For more information, visit: and

Stocks in the news and acting well as of late include: Cendant Corp. (NYSE: CD), Solar Enertech Corp. (OTCBB: SOEN), and ViroPharma Inc. (NASDAQ: VPHM).

Information contained herein is the opinion of ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated in free trading shares of common stock, available for public trading as follows: Tasco Holdings International, Inc. compensation from a third party shareholder: twenty five thousand free trading shares of stock in Tasco Holdings International, Inc., already delivered from a third party shareholder. To date, MP has sold zero shares of stock in Tasco Holdings International, Inc. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. and Market Pulse Breaking News Alert are owned by Market Pulse LLC.

Contact Information